ReviewArrhythmia & electrophysiology review2026
Toward a Prospective Definition of Atrial Fibrillation-induced Cardiomyopathy.
Review in Arrhythmia & electrophysiology review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
AF can mediate left ventricular systolic dysfunction (LVSD) through a tachycardia-mediated cardiomyopathic process that may reverse with rate control alone. However, additional mechanisms contribute to AF-induced cardiomyopathy (AIC) that require rhythm control therapies. AIC can currently only be diagnosed retrospectively, as these component mechanisms are difficult to distinguish from each other and from other causes of LVSD prospectively. This narrative review considers the different potential mechanisms through which AF can impair ventricular function: rapid ventricular rate; irregularity of the ventricular rhythm; and impaired atrial contraction. How these features may exploit underlying structural vulnerability are considered and additional imaging-based parameters such as late gadolinium enhancement on cardiac MRI and contractile reserve during stress echocardiography are discussed. The limitations of existing parameters are discussed and a novel, non-parametric marker of ventricular rate with consideration of the inherent irregularity of AF - the Restitution Threshold Index (RTI) - is reviewed. Integrating RTI with these imaging-based measures may enhance clinical decision-making by more accurately identifying patients who would benefit from timely rhythm control. Further prospective validation is essential to develop accessible tools and an open-access RTI calculator has been made available (https://restitutionthreshold.com) to facilitate reproducibility and wider application.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.